Hunan Wutian Pharmaceutical Co., Ltd.

Hunan Wutian Pharmaceutical Co., Ltd. was established in April 2005 with a registered capital of 50 million RMB. The company currently has over 100 high-quality sales representatives, and its marketing network has covered medical institutions at all levels across the province and cities, as well as pharmaceutical wholesale enterprises at the city and county levels. In order to meet hospital formulation needs, the company also provides over 70 types of raw materials such as glucose, mannitol, and silver sulfadiazine to major hospitals.
For over 8 years, the company has been an agent for products from Kelun Pharmaceutical and its 32 subsidiary drug manufacturing enterprises, including 512 varieties of drugs in 17 dosage forms such as infusions, small water injections, powder injections, lyophilized powder injections, tablets, capsules, granules, and oral liquids. Among them, the upright polypropylene infusion bag (also known as Kelidai), which represents the latest technological level of infusion products in China's national pharmaceutical industry, has been warmly welcomed and fully recognized by medical and nursing professionals, and has high clinical application value. It provides patients with the safest infusion products to date. Currently, the coverage rate of this product in hospitals within the province has reached 80%. In 2013, the company's sales exceeded 800 million RMB, creating nearly 10 million RMB in profits and taxes. While creating social wealth, the company also actively fulfills its social responsibilities. Over the years, it has actively donated money and materials during various natural disasters such as ice storms and earthquakes. The company will adhere to the modern business philosophy of integrity, pragmatism, efficiency, and innovation, advocate that no pains, no gains, and uphold the principles of quality first, service supreme, and shared prosperity with customers. It will fully utilize its market sales network covering the entire province, leverage its established brand advantages in the fields of infusions and raw materials, continue to adjust and optimize its product structure based on existing sales varieties, and further enhance its market share in the provincial pharmaceutical market; at the same time, actively promote the development of agency distribution and delivery business for imported and joint-venture products, seek new growth points in scale and profit, and continuously strengthen the company's competitiveness. We firmly believe that only through word-of-mouth from every customer can we ride the waves in the pharmaceutical business sea, continue to grow and develop, and strive forward!